These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 30413173)

  • 1. Two histologically colorectal carcinomas subsets from the serrated pathway show different methylome signatures and diagnostic biomarkers.
    García-Solano J; Turpin MC; Torres-Moreno D; Huertas-López F; Tuomisto A; Mäkinen MJ; Conesa A; Conesa-Zamora P
    Clin Epigenetics; 2018 Nov; 10(1):141. PubMed ID: 30413173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in gene expression profiling and biomarkers between histological colorectal carcinoma subsets from the serrated pathway.
    García-Solano J; Turpin-Sevilla MDC; García-García F; Carbonell-Muñoz R; Torres-Moreno D; Conesa A; Conesa-Zamora P
    Histopathology; 2019 Oct; 75(4):496-507. PubMed ID: 31025430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-181a-2* expression is different amongst carcinomas from the colorectal serrated route.
    Kondelova A; Alburquerque-González B; Vychytilova-Faltejskova P; García-Solano J; Prochazka V; Kala Z; Pérez F; Slaby O; Conesa-Zamora P
    Mutagenesis; 2020 Jul; 35(3):233-241. PubMed ID: 31784758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylome profiling reveals functions and genes which are differentially methylated in serrated compared to conventional colorectal carcinoma.
    Conesa-Zamora P; García-Solano J; Turpin Mdel C; Sebastián-León P; Torres-Moreno D; Estrada E; Tuomisto A; Wilce J; Mäkinen MJ; Pérez-Guillermo M; Conesa A
    Clin Epigenetics; 2015; 7(1):101. PubMed ID: 26388956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression profiling shows differential molecular pathways and provides potential new diagnostic biomarkers for colorectal serrated adenocarcinoma.
    Conesa-Zamora P; García-Solano J; García-García F; Turpin Mdel C; Trujillo-Santos J; Torres-Moreno D; Oviedo-Ramírez I; Carbonell-Muñoz R; Muñoz-Delgado E; Rodriguez-Braun E; Conesa A; Pérez-Guillermo M
    Int J Cancer; 2013 Jan; 132(2):297-307. PubMed ID: 22696308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
    Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
    World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global Methylome Scores Correlate with Histological Subtypes of Colorectal Carcinoma and Show Different Associations with Common Clinical and Molecular Features.
    Turpín-Sevilla MDC; Pérez-Sanz F; García-Solano J; Sebastián-León P; Trujillo-Santos J; Carbonell P; Estrada E; Tuomisto A; Herruzo I; Fennell LJ; Mäkinen MJ; Rodríguez-Braun E; Whitehall VLJ; Conesa A; Conesa-Zamora P
    Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway.
    Kim JH; Bae JM; Cho NY; Kang GH
    Oncotarget; 2016 Mar; 7(12):14095-111. PubMed ID: 26883113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colorectal serrated adenocarcinoma shows a different profile of oncogene mutations, MSI status and DNA repair protein expression compared to conventional and sporadic MSI-H carcinomas.
    García-Solano J; Conesa-Zamora P; Carbonell P; Trujillo-Santos J; Torres-Moreno D D; Pagán-Gómez I; Rodríguez-Braun E; Pérez-Guillermo M
    Int J Cancer; 2012 Oct; 131(8):1790-9. PubMed ID: 22287190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment and characterization of cell lines from chromosomal instable colorectal cancer.
    Maletzki C; Gock M; Randow M; Klar E; Huehns M; Prall F; Linnebacher M
    World J Gastroenterol; 2015 Jan; 21(1):164-76. PubMed ID: 25574089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers for the identification of precursor polyps of colorectal serrated adenocarcinomas.
    García-Solano J; García-Solano ME; Torres-Moreno D; Carbonell P; Trujillo-Santos J; Pérez-Guillermo M; Conesa-Zamora P
    Cell Oncol (Dordr); 2016 Jun; 39(3):243-52. PubMed ID: 26832730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Annexin A10 expression correlates with serrated pathway features in colorectal carcinoma with microsatellite instability.
    Kim JH; Rhee YY; Kim KJ; Cho NY; Lee HS; Kang GH
    APMIS; 2014 Dec; 122(12):1187-95. PubMed ID: 24909058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathologic and molecular characteristics of synchronous colorectal cancers: heterogeneity of clinical outcome depending on microsatellite instability status of individual tumors.
    Bae JM; Cho NY; Kim TY; Kang GH
    Dis Colon Rectum; 2012 Feb; 55(2):181-90. PubMed ID: 22228162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic and epigenetic aberrations occurring in colorectal tumors associated with serrated pathway.
    Sakai E; Fukuyo M; Ohata K; Matsusaka K; Doi N; Mano Y; Takane K; Abe H; Yagi K; Matsuhashi N; Fukushima J; Fukayama M; Akagi K; Aburatani H; Nakajima A; Kaneda A
    Int J Cancer; 2016 Apr; 138(7):1634-44. PubMed ID: 26510091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serrated colorectal cancer: Molecular classification, prognosis, and response to chemotherapy.
    Murcia O; Juárez M; Hernández-Illán E; Egoavil C; Giner-Calabuig M; Rodríguez-Soler M; Jover R
    World J Gastroenterol; 2016 Apr; 22(13):3516-30. PubMed ID: 27053844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Subtypes of Colorectal Cancer and Their Clinicopathologic Features, With an Emphasis on the Serrated Neoplasia Pathway.
    Bae JM; Kim JH; Kang GH
    Arch Pathol Lab Med; 2016 May; 140(5):406-12. PubMed ID: 27128298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples.
    Gallardo-Gómez M; Moran S; Páez de la Cadena M; Martínez-Zorzano VS; Rodríguez-Berrocal FJ; Rodríguez-Girondo M; Esteller M; Cubiella J; Bujanda L; Castells A; Balaguer F; Jover R; De Chiara L
    Clin Epigenetics; 2018; 10():53. PubMed ID: 29686738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Walking pathways with positive feedback loops reveal DNA methylation biomarkers of colorectal cancer.
    Kel A; Boyarskikh U; Stegmaier P; Leskov LS; Sokolov AV; Yevshin I; Mandrik N; Stelmashenko D; Koschmann J; Kel-Margoulis O; Krull M; Martínez-Cardús A; Moran S; Esteller M; Kolpakov F; Filipenko M; Wingender E
    BMC Bioinformatics; 2019 Apr; 20(Suppl 4):119. PubMed ID: 30999858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylation and expression of the tumour suppressor, PRDM5, in colorectal cancer and polyp subgroups.
    Bond CE; Bettington ML; Pearson SA; McKeone DM; Leggett BA; Whitehall VL
    BMC Cancer; 2015 Jan; 15():20. PubMed ID: 25613750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The serrated neoplasia pathway of colorectal tumors: Identification of MUC5AC hypomethylation as an early marker of polyps with malignant potential.
    Renaud F; Mariette C; Vincent A; Wacrenier A; Maunoury V; Leclerc J; Coppin L; Crépin M; Van Seuningen I; Leteurtre E; Buisine MP
    Int J Cancer; 2016 Mar; 138(6):1472-81. PubMed ID: 26476272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.